Navigating the landscape of Trigeminal Autonomic Cephalalgias (TACs) requires a structured approach to clinical assessment
The primary TAC conditions—Cluster Headache, Paroxysmal Hemicrania, SUNCT/SUNA, and Hemicrania Continua—can be compared across several diagnostic axes
Epidemiology and Gender Distribution: Cluster headache displays a clear male predominance (1:3 to 1:7 female-to-male ratio)
. Paroxysmal hemicrania shows a slight female predominance (1:1 to 2.7:1) . SUNCT/SUNA displays a slight male emphasis (1:1.5) . Hemicrania Continua exhibits a strong female predominance (2:1 female-to-male ratio) . Pain Quality and Severity: Cluster headache pain is excruciating, stabbing, or boring
. Paroxysmal hemicrania pain is sharp, stabbing, or throbbing . SUNCT/SUNA pain is severe to excruciating, burning, stabbing, or sharp . Hemicrania Continua presents with continuous, mild-to-severe throbbing, dull, or aching pain with periodic sharp exacerbations . Temporal Dynamics: Cluster headache attacks last 15–180 minutes, occurring 1 to 8 times daily
. Paroxysmal hemicrania lasts 2–30 minutes, occurring 1 to 40 times daily . SUNCT/SUNA attacks last 1–600 seconds, occurring 1 to 200 times daily . Hemicrania Continua features continuous pain persisting for months to years . Triggers and Behavior: Alcohol acts as a reliable trigger for cluster headache and occasionally for paroxysmal hemicrania or hemicrania continua, but not for SUNCT
. Cutaneous sensory triggers are unique to SUNCT/SUNA . Restlessness and physical agitation are common across Cluster, Paroxysmal Hemicrania, and Hemicrania Continua . Indomethacin Effect: Indomethacin provides an absolute, complete therapeutic response in Paroxysmal Hemicrania and Hemicrania Continua, while offering no therapeutic benefit in Cluster Headache or SUNCT/SUNA
.
Treatment selection varies according to these distinct clinical profiles